Art

J-GLOBAL ID：202002248288539364   Reference number：20A2140391

Comparison of thyroid hormone withdrawal and recombinant human thyroid-stimulating hormone administration for adjuvant therapy in patients with intermediate- to high-risk differentiated thyroid cancer

中から高リスクの分化型甲状腺癌患者におけるアジュバント療法のための甲状腺ホルモン休薬と遺伝子組換えヒト甲状腺刺激ホルモン投与の比較

Author (6)： Iizuka Yusuke (Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, Kyoto, Japan) ,  Katagiri Tomohiro (Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, Kyoto, Japan) ,  Ogura Kengo (Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, Kyoto, Japan) ,  Inoue Minoru (Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, Kyoto, Japan) ,  Nakamura Kiyonao (Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, Kyoto, Japan) ,  Mizowaki Takashi (Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, Kyoto, Japan)
Material： Annals of Nuclear Medicine  (Ann Nucl Med)
Volume： 34  Issue： 10  Page： 736-741  Publication year： Oct. 2020 
JST Material Number： X0838A  ISSN： 0914-7187  CODEN： ANMEEX  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Differentiated thyroid carcinoma ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2140391&from=J-GLOBAL&jstjournalNo=X0838A") }}

Author keywords (4)： Differentiated thyroid cancer ,  Adjuvant therapy ,  Intermediate-to-high risk ,  Retrospective study

JST classification (2)： Radiotherapy for tumors  (GE03034K) ,  Tumors(=neoplasms)of endocrine system  (GL04000P)

Terms in the title (10)： リスク ,  分化型甲状腺癌 ,  患者 ,  アジュバント療法 ,  甲状腺ホルモン ,  休薬 ,  遺伝子組換え ,  ヒト ,  甲状腺刺激ホルモン ,  投与